Mabwell (shanghai) Bioscience Co., Ltd. Class ASSE: 688062

"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Voluntary Disclosure of the Approval by the National Medical Products Administration of the Clinical Trial Application for 9MW5211 Injection

· Issued by Mabwell (shanghai) Bioscience Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of the Approval by the National Medical Products Administration of the Clinical Trial Application for 9MW5211 Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Mabwell (shanghai) Bioscience Co., Ltd. Class A

All Mabwell (shanghai) Bioscience Co., Ltd. Class A news releases